These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats. DiPetrillo K; Gesek FA Am J Nephrol; 2004; 24(3):352-9. PubMed ID: 15205554 [TBL] [Abstract][Full Text] [Related]
10. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications]. Hotta N; Sakamoto N Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677 [No Abstract] [Full Text] [Related]
11. New hope for ending complications. Working together to protect your body from diabetes damage. Gebel E Diabetes Forecast; 2012 Apr; 65(4):56, 59-60. PubMed ID: 22582527 [No Abstract] [Full Text] [Related]
12. Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug? Bhanot S; Leehey DJ Curr Hypertens Rep; 2016 Jan; 18(1):8. PubMed ID: 26747265 [TBL] [Abstract][Full Text] [Related]
13. [Effects of pentoxifylline on the ocular rheographic pulse in diabetic patients]. Colombati S; Monti L; Baggiani M; Filippini F Ric Clin Lab; 1989; 19 Suppl 1():185-7. PubMed ID: 2629085 [No Abstract] [Full Text] [Related]
14. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients. Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021 [TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline and diabetic neuropathy. Sainati SM Diabetes Care; 1991 Oct; 14(10):930. PubMed ID: 1812883 [No Abstract] [Full Text] [Related]
16. Pentoxifylline and diabetic neuropathy. Cohen KL; Harris S Ann Intern Med; 1987 Oct; 107(4):600-1. PubMed ID: 3631805 [No Abstract] [Full Text] [Related]
17. Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats. Baraka AM; Guemei A; Gawad HA Biochem Pharmacol; 2010 Jun; 79(11):1634-9. PubMed ID: 20144589 [TBL] [Abstract][Full Text] [Related]
19. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. Valencia WM; Florez H BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Navarro-González JF; Jarque A; Muros M; Mora C; García J Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]